Dynamic Technology Lab’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Dynamic Technology Lab’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-54,751	Closed	-$735K	–	1522
2023 Q1	$735K	Buy	54,751 +39,588	+261%	+$685K	0.07%	496
2022 Q4	$187K	Buy	+15,163	New	+$215K	0.02%	927
2020 Q2	–	Sell	-4,918	Closed	-$310K	–	1437
2020 Q1	$310K	Buy	+4,918	New	+$442K	0.06%	572
2019 Q1	–	Sell	-2,359	Closed	-$237K	–	1409
2018 Q4	$237K	Buy	+2,359	New	+$245K	0.04%	748
2017 Q3	–	Sell	-6,798	Closed	-$824K	–	1448
2017 Q2	$824K	Buy	6,798 +3,136	+86%	+$363K	0.16%	168
2017 Q1	$414K	Buy	+3,662	New	+$428K	0.1%	391

Other funds holding ICPT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

DCM

DG Capital Management New York $326M AUM 39.67% 1-Year Est. Return

Dynamic Technology Lab's ICPT Position: Q2 2023 in Review

Dynamic Technology Lab sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q2 2023, closing a stake of 54,751 shares — an estimated $735K sold.

Dynamic Technology Lab first reported a position in ICPT in Q1 2017 and held it in 6 quarters. The position peaked at $824K in Q2 2017. 126 funds tracked by Wall St. Rank hold ICPT as of Q2 2023.

Dynamic Technology Lab reported no remaining Intercept Pharmaceuticals, Inc. position as of Q2 2023 after selling out during the quarter.
Dynamic Technology Lab sold 54,751 Intercept Pharmaceuticals, Inc. shares in Q2 2023, an estimated $735K.
Dynamic Technology Lab first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2017 and held it in 6 quarters.
Dynamic Technology Lab's Intercept Pharmaceuticals, Inc. position peaked at $824K in Q2 2017.
126 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q2 2023.

Based on Dynamic Technology Lab's 13F filing for Q2 2023, filed 14 Aug 2023.